Details for New Drug Application (NDA): 006035
✉ Email this page to a colleague
NDA 006035 describes METHERGINE, which is a drug marketed by Edison Theraps Llc and is included in one NDA. Additional details are available on the METHERGINE profile page.
The generic ingredient in METHERGINE is methylergonovine maleate. There is one drug master file entry for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the methylergonovine maleate profile page.
The generic ingredient in METHERGINE is methylergonovine maleate. There is one drug master file entry for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the methylergonovine maleate profile page.
Summary for 006035
| Tradename: | METHERGINE |
| Applicant: | Edison Theraps Llc |
| Ingredient: | methylergonovine maleate |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 006035
Profile for product number 003
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 0.2MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | Yes | |||||
Profile for product number 004
| Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | 0.2MG/ML | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | AP | RLD: | Yes | ||||
Complete Access Available with Subscription
